Advanced search
Publication Cover
Acta Oncologica Volume 51, 2012 - Issue 4
Journal homepage
1,671
Views
26
CrossRef citations to date
0
Altmetric
Research Article

Imatinib efficacy by tumor genotype in Korean patients with advanced gastrointestinal stromal tumors (GIST): The Korean GIST Study Group (KGSG) study

Hye Jin KangDivision of Hematology/Oncology, Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Korea
,
Min-Hee RyuDepartment of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
,
Kyoung-Mee KimDepartment of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
,
Young Soo ParkDepartment of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
,
Jene ChoiDepartment of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
,
Baek-Yeol RyooDepartment of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
,
Woo Ho KimDepartment of Pathology, Seoul National University College of Medicine, Seoul, Korea
,
Seock-Ah ImDepartment of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea
,
Yung-Jue BangDepartment of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea
,
Se Hoon ParkDivision of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
,
Jae-Hyuk LeeDepartment of Pathology, Chonnam National University Hwasun Hospital, Hwasun-gun, Korea
,
Ik Joo ChungDepartment of Oncology, Chonnam National University Hwasun Hospital, Hwasun-gun, Korea
,
Han-Ik BaeDepartment of Pathology, Kyungpook National University School of Medicine, Daegu, Korea
,
Jong Gwang KimDepartment of Oncology/Hematology, Kyungpook National University School of Medicine, Daegu, Korea
,
Kyung Hee LeeDepartment of Hemato-Oncology, Yeung Nam University Hospital, Daegu, Korea
,
Hong Suk SongSection of Hemato-Oncology, Department of Internal Medicine, Keimyung University Dongsan Medical Center, Daegu, Korea
,
Hyuk-Chan KwonDepartment of Internal Medicine, Dong-A university Medical Center, Busan, Korea
,
Jin Ho BaekDivision of Hematology-Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea
,
Dong Bok ShinDepartment of Oncology/Hematology, Gachon Medicine and Science University Hospital, Incheon, Korea
,
Kyoung Eun LeeDivision of Hematology-Oncology, School of Medicine, Ewha Womans University, Seoul, Korea
&
Yoon-Koo KangDepartment of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, KoreaCorrespondence[email protected]
 show all
Pages 528-536 | Received 05 Aug 2011, Accepted 19 Oct 2011, Published online: 07 Dec 2011

Citations (26)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Zhiqiang Jiang, Jian Zhang, Zhi Li, Yingjun Liu, Daohai Wang & Guangsen Han. (2016) A meta-analysis of prognostic value of KIT mutation status in gastrointestinal stromal tumors. OncoTargets and Therapy 9, pages 3387-3398.
Read now
Gianluca Spitaleri, Roberto Biffi, Massimo Barberis, Caterina Fumagalli, Francesca Toffalorio, Chiara Catania, Cristina Noberasco, Chiara Lazzari, Filippo de Marinis & Tommaso De Pas. (2015) Inactivity of imatinib in gastrointestinal stromal tumors (GISTs) harboring a KIT activation-loop domain mutation (exon 17 mutation pN822K). OncoTargets and Therapy 8, pages 1997-2003.
Read now
Brian K Bednarski, Peter WT Pisters & Kelly K Hunt. (2012) The role of surgery in the multidisciplinary management of patients with localized gastrointestinal stromal tumors. Expert Review of Anticancer Therapy 12:8, pages 1069-1078.
Read now

Articles from other publishers (23)

Nour Pharaon, Wafa Habbal & Fawza Monem. (2023) Bioinformatic analysis of KIT juxtamembrane domain mutations in Syrian GIST patients: jigsaw puzzle completed. Journal of the Egyptian National Cancer Institute 35:1.
Crossref
Yeong Hak Bang, Min‐Hee Ryu, Hyung‐Don Kim, Hyung Eun Lee & Yoon‐Koo Kang. (2022) Clinical outcomes and prognostic factors for patients with high‐risk gastrointestinal stromal tumors treated with 3‐year adjuvant imatinib. International Journal of Cancer 151:10, pages 1770-1777.
Crossref
Yingying Xu, Wenqing Hu, Keyuan Xiao, Feng Wang, Wenxian Guan & Liang Zong. (2022) The current state of chemotherapy for the treatment of gastrointestinal stromal tumors with different genotypes: a narrative review. Journal of Bio-X Research 5:1, pages 14-17.
Crossref
Liangliang Xu, Ming Zhang & Mingqing Xu. (2019) Primary hepatic gastrointestinal stromal tumor with right adrenal gland invasion. Medicine 98:20, pages e15482.
Crossref
Jwa Hoon Kim, Min‐Hee Ryu, Changhoon Yoo, Heejung Chae, Hana Na, Moyoul Beck, Beom Su Kim, Moon‐Won Yoo, Jeong Hwan Yook, Byung Sik Kim, Ki‐Hun Kim, Chan Wook Kim & Yoon‐Koo Kang. (2019) Long‐term survival outcome with tyrosine kinase inhibitors and surgical intervention in patients with metastatic or recurrent gastrointestinal stromal tumors: A 14‐year, single‐center experience. Cancer Medicine 8:3, pages 1034-1043.
Crossref
Pieter A. Boonstra, Jourik A. Gietema, Albert J.H. Suurmeijer, Matthew R. Groves, Fernando de Assis Batista, Ed Schuuring & Anna K.L. Reyners. (2017) Tyrosine kinase inhibitor sensitive PDGFRΑ mutations in GIST: Two cases and review of the literature. Oncotarget 8:65, pages 109836-109847.
Crossref
David Guenat, Olivier Deroo, Sandrine Magnin, Loïc Chaigneau, Franck Monnien, Christophe Borg, Christiane Mougin, Jean-François Emile & Jean-Luc Prétet. (2017) Somatic mutational spectrum analysis in a prospective series of 104 gastrointestinal stromal tumors. Oncology Reports 37:3, pages 1671-1681.
Crossref
Anant Ramaswamy, Vikas Ostwal, Omshree Shetty, Arvind Sahu, Davinder Paul, Trupti Pai, Mamta Gurav, Nitin Shetty & Shailesh Shrikhande. (2016) Neoadjuvant Imatinib in Locally Advanced Gastrointestinal stromal Tumours, Will Kit Mutation Analysis Be a Pathfinder?. Journal of Gastrointestinal Cancer 47:4, pages 381-388.
Crossref
Dong-Hoe Koo, Min-Hee Ryu, Kyoung-Mee Kim, Han-Kwang Yang, Akira Sawaki, Seiichi Hirota, Jie Zheng, Bo Zhang, Chin-Yuan Tzen, Chun-Nan Yeh, Toshirou Nishida, Lin Shen, Li-Tzong Chen & Yoon-Koo Kang. (2016) Asian Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Stromal Tumor. Cancer Research and Treatment 48:4, pages 1155-1166.
Crossref
Tania Fleitas, Maider Ibarrola-Villava, Gloria Ribas & Andrés Cervantes. (2016) MassARRAY determination of somatic oncogenic mutations in solid tumors: Moving forward to personalized medicine. Cancer Treatment Reviews 49, pages 57-64.
Crossref
Changhoon Yoo, Min-Hee Ryu, Jungmin Jo, Inkeun Park, Baek-Yeol Ryoo & Yoon-Koo Kang. (2016) Efficacy of Imatinib in Patients with Platelet-Derived Growth Factor Receptor Alpha–Mutated Gastrointestinal Stromal Tumors. Cancer Research and Treatment 48:2, pages 546-552.
Crossref
Daniel S.W. TanTony S.K. MokTimothy R. Rebbeck. (2016) Cancer Genomics: Diversity and Disparity Across Ethnicity and Geography. Journal of Clinical Oncology 34:1, pages 91-101.
Crossref
Lin Yan, Lei Zou, Wenhua Zhao, Yansen Wang, Bo Liu, Hongliang Yao & Haihua Yu. (2015) Clinicopathological significance of c-KIT mutation in gastrointestinal stromal tumors: a systematic review and meta-analysis. Scientific Reports 5:1.
Crossref
Dong-Hoe Koo, Min-Hee Ryu, Baek-Yeol Ryoo, Mo Youl Beck, Young-Soon Na, Jae-Gook Shin, Sang Seop Lee, Eun-Young Kim & Yoon-Koo Kang. (2014) Association of ABCG2 polymorphism with clinical efficacy of imatinib in patients with gastrointestinal stromal tumor. Cancer Chemotherapy and Pharmacology 75:1, pages 173-182.
Crossref
Brian K. Bednarski, Dejka M. Araujo, Min Yi, Keila E. Torres, Alexander Lazar, Jonathan C. Trent, Janice N. Cormier, Peter W. T. Pisters, Dina Chelouche Lev, Raphael E. Pollock, Barry W. Feig & Kelly K. Hunt. (2014) Analysis of Prognostic Factors Impacting Oncologic Outcomes After Neoadjuvant Tyrosine Kinase Inhibitor Therapy for Gastrointestinal Stromal Tumors. Annals of Surgical Oncology 21:8, pages 2499-2505.
Crossref
Ho Jung An, Min-Hee Ryu, Baek-Yeol Ryoo, Byeong Seok Sohn, Ki-Hun Kim, Sung Tae Oh, Chang Sik Yu, Jeong Hwan Yook, Byung Sik Kim & Yoon-Koo Kang. (2013) The Effects of Surgical Cytoreduction Prior to Imatinib Therapy on the Prognosis of Patients with Advanced GIST. Annals of Surgical Oncology 20:13, pages 4212-4218.
Crossref
Xiaofei Zhi, Xiaoying Zhou, Weizhi Wang & Zekuan Xu. (2013) Practical Role of Mutation Analysis for Imatinib Treatment in Patients With Advanced Gastrointestinal Stromal Tumors: A Meta-Analysis. PLoS ONE 8:11, pages e79275.
Crossref
Jean-Baptiste Bachet, Bruno Landi, Pierre Laurent-Puig, Antoine Italiano, Axel Le Cesne, Philippe Lévy, Violaine Safar, Florence Duffaud, Jean-Yves Blay & Jean-François Emile. (2013) Diagnosis, prognosis and treatment of patients with gastrointestinal stromal tumour (GIST) and germline mutation of KIT exon 13. European Journal of Cancer 49:11, pages 2531-2541.
Crossref
Sabrina AngeliniGloria Ravegnini, Jonathan A Fletcher, Francesca Maffei & Patrizia Hrelia. (2013) Clinical relevance of pharmacogenetics in gastrointestinal stromal tumor treatment in the era of personalized therapy. Pharmacogenomics 14:8, pages 941-956.
Crossref
Yoon-Koo KangDong Hoe Koo. (2013) Diagnosis and Treatment of Gastrointestinal Stromal Tumor. Korean Journal of Medicine 85:4, pages 341.
Crossref
Jing Gao, Yunzhi Dang, Naiping Sun, Jian Li & Lin Shen. (2012) C-KIT mutations were closely associated with the response to Imatinib in Chinese advanced gastrointestinal stromal tumor patients. Medical Oncology 29:5, pages 3039-3045.
Crossref
Guhyun Kang, Jeeyun Lee, Ki Taek Jang, Carol Beadling, Chistopher L. Corless, Micheal C. Heinrich, Joon Oh Park, Won Ki Kang, Cheol Keun Park & Kyoung-Mee Kim. (2012) Multiplex mutation screening by mass spectrometry in gastrointestinal stromal tumours. Pathology 44:5, pages 460-464.
Crossref
Yoon-Koo Kang, Hye Jin Kang, Kyoung-Mee Kim, Taesung Sohn, Dongil Choi, Min-Hee Ryu, Woo Ho Kim & Han-Kwang Yang. (2012) Clinical Practice Guideline for Accurate Diagnosis and Effective Treatment of Gastrointestinal Stromal Tumor in Korea. Cancer Research and Treatment 44:2, pages 85-96.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.